This paper considers the problem of modeling disease progression from historical clinical databases, with the ultimate objective of stratifying patients into groups with clearly d...
Ronald K. Pearson, Robert J. Kingan, Alan Hochberg
If imaging is to serve as a valid biomarker in the assessment of the response of cancer to therapies, a reproducible and predictive radiologic metric is required. A biomarker is an...